The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Related Articles
Synthetic anti-RNA antibody derivatives for RNA visualization in mammalian cells
Abstract. Although antibody derivatives, such as Fabs and scFvs, have revolutionized the cellular imaging, quantification and tracking of proteins, analogo
Brief Report: Evaluating Early-Stage Lung Cancer Survival Patterns in Patients at the Upper Age Limit for Lung Cancer Screening
Older individuals have an elevated lung cancer risk but may also have significant comorbidities that preclude curative treatment options and limit the survival benefits of…
Opinion | The 73 Percent Solution
Whenever someone agrees wholeheartedly with something I write, I die a little inside.
Unweaving the Rainbow: Science, Delusion and the Appetite for Wonder
Unweaving the Rainbow: Science, Delusion and the Appetite for Wonder
Exploring the diverse definitions of ‘evidence’: a scoping review
Objectives To systematically collect and analyse diverse definitions of ‘evidence’ in both health and social sciences, and help users to correctly use the term ‘evidence’…
Imaging Features in the Liver after Stereotactic Body Radiation Therapy | RadioGraphics
Historically, radiation therapy was not considered in treatment of liver tumors owing to the risk of radiation-induced liver disease. However, development of highly conformed radiation…
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
Mitochondrial fatty acid oxidation drives senescence
Nuclear DNA damage activates fatty acid–fueled mitochondrial energy metabolism to induce cellular senescence, a hallmark of aging.
Archived Issues of Oncotarget | Oncotarget
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal that has been publishing research since 2010
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
The WHO and International Consensus Classification 2022 classifications of myelodysplastic syndromes enhance diagnostic precision and refine decision-making processes in these diseases. However, some discrepancies still…
